Session

Management of refractory Crohn's disease

DISAPPEARANCE OF ANTI-DRUG ANTIBODIES TO INFLIXIMAB AND ADALIMUMAB AFTER ADDITION OF AN IMMUNOMODULATOR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Anne Strik

Management of extensive small bowel Crohn's disease: The gastroenterologist's view

Severine Vermeire

Management of extensive small bowel Crohn's disease: The surgeon's view

Gianluca M Sampietro

POST-OPERATIVE COMPLICATIONS IN ELDERLY-ONSET INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED STUDY

Sophie-Caroline Sacleux

Refractory perianal fistulising disease: The gastroenterologist's view & The surgeon's view

Carolynne Vaizey, James Lindsay

What to do when all biologics fail?

Jean-Frederic Colombel

Item 1 - 6 / 6
1